CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Largest, Longest Real-World Study of Migraine in U.S. Veterans Finds that Nerivio® Helps Patients Successfully Skip Prescribed Migraine Medications in 3-out-of-4 of Their Migraine Attacks

Data ReadoutpositiveNerivio®Positive
AI Analysis

Summary

Theranica announced peer-reviewed real-world data from nearly 30,000 treatments showing Nerivio®, a drug-free wearable device, helped U.S. veterans successfully skip prescribed migraine medications in 75% of migraine attacks, reinforcing its role as an alternative treatment option.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Real-world study of nearly 30,000 migraine treatments in U.S. veterans found Nerivio® helped patients skip prescribed migraine medications in 3 out of 4 migraine attacks

Importance:6/10
Sentiment:
0.75
real-world studyveteransmigrainedrug-free wearablepeer-reviewedREN technology
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on August 6, 2026 1:06 PM

Read Original